H 5159 Massachusetts House · 193rd Legislature (2023-2024)

An Act enhancing the market review process

This bill updates the Massachusetts Health Policy Commission by redefining key terms and adjusting the composition of its governing board. It introduces new definitions for concepts such as "health equity," "significant equity investor," and various healthcare entities like pharmacy benefit managers and private equity companies to clarify who is regulated. The legislation also changes how the commission's board is formed, specifying that members will be appointed by the governor, state officials, and legislative leaders rather than solely by the Department of Public Health. Additionally, the bill repeals previous sections related to medical assistance divisions and modifies the oversight structure for the commission. These changes aim to refine the legal framework used to review and regulate the state's healthcare market.
Bill status passed both 4 of 5 stages cleared
Introduction
Dec 2024
Committee Review
Dec 2024
House Passage
Dec 2024
Senate Passage
Dec 2024
Governor
Introduced Dec 30, 2024 Last action Dec 30, 2024
Floor votes

How they voted

This bill passed the Senate. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
10
Key actions
6
Committee
5
Dec 30, 2024
Upper · Passed
Enacted and laid before the Governor
upper
Dec 30, 2024
Lower · Passed
Enacted
lower
Dec 30, 2024
Upper · Passed
Committee of conference report accepted, in concurrence
upper
Dec 30, 2024
Lower · Passed
Committee of conference report accepted
lower
Dec 30, 2024
Lower · Passed
Committee reported that the matter be placed in the Orders of the Day for the next sitting, the question being on acceptance
lower
Dec 30, 2024
Committee
Referred to the committee on House Steering, Policy and Scheduling
lower
Dec 30, 2024
Lower · Passed
Reported from the committee on conference
lower
0 primary · 66 co-sponsors

Sponsors

No sponsor information available.